MAPLE HEALTHCARE PTY LTD

LEVEL 8 555 BOURKE STREET, Melbourne, Victoria, Australia

Clinical Trials

0 active

Approvals

170

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

No trial data available

Clinical Trials

No trial data available

Approvals

Approvals by Agency

TGA

Therapeutic Goods Administration

170

Approvals

Recent Approvals

VARENICLINE VIATRIS varenicline (as tartrate) 1 mg tablet blister pack (509805)

TGA

2025-10-31

VARENICLINE VIATRIS varenicline (as tartrate) 1 mg tablet blister pack (509805)

TGA

2025-10-31

MAPLE DOCU-SENNA docusate sodium 50 mg and sennosides A and B 8 mg film coated tablet bottle (517732)

TGA

2025-10-30

MAPLE DOCU-SENNA docusate sodium 50 mg and sennosides A and B 8 mg film coated tablet bottle (517732)

TGA

2025-10-30

OYONE 40/20 oxycodone hydrochloride 40 mg / naloxone hydrochloride 20 mg modified release tablet blister pack (462787)

TGA

2025-10-20

OYONE 20/10 oxycodone hydrochloride 20 mg / naloxone hydrochloride 10 mg modified release tablet blister pack (462785)

TGA

2025-10-20

OXYCODONE NALOXONE MAPLE 40/20 oxycodone hydrochloride 40 mg / naloxone hydrochloride 20 mg modified release tablet blister pack (462793)

TGA

2025-10-20

OYONE 10/5 oxycodone hydrochloride 10 mg / naloxone hydrochloride 5 mg modified release tablet blister pack (461919)

TGA

2025-10-20

OXYCODONE NALOXONE MAPLE 5/2.5 oxycodone hydrochloride 5 mg / naloxone hydrochloride 2.5 mg modified release tablet blister pack (462789)

TGA

2025-10-20

OYONE 30/15 oxycodone hydrochloride 30 mg / naloxone hydrochloride 15 mg modified release tablet blister pack (462786)

TGA

2025-10-20

News

No news articles found

Back to Organizations